Haemonetics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Haemonetics and other ETFs, options, and stocks.

About HAE

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital. 

CEO
Christopher A. Simon
CEOChristopher A. Simon
Employees
3,023
Employees3,023
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
1971
Founded1971
Employees
3,023
Employees3,023

HAE Key Statistics

Market cap
3.78B
Market cap3.78B
Price-Earnings ratio
23.56
Price-Earnings ratio23.56
Dividend yield
Dividend yield
Average volume
950.14K
Average volume950.14K
High today
$80.86
High today$80.86
Low today
$79.65
Low today$79.65
Open price
$80.32
Open price$80.32
Volume
597.12K
Volume597.12K
52 Week high
$89.69
52 Week high$89.69
52 Week low
$47.32
52 Week low$47.32

Stock Snapshot

As of today, Haemonetics(HAE) shares are valued at $80.75. The company's market cap stands at 3.78B, with a P/E ratio of 23.56.

On 2025-11-28, Haemonetics(HAE) stock traded between a low of $79.65 and a high of $80.86. Shares are currently priced at $80.75, which is +1.4% above the low and -0.1% below the high.

Haemonetics(HAE) shares are trading with a volume of 597.12K, against a daily average of 950.14K.

In the last year, Haemonetics(HAE) shares hit a 52-week high of $89.69 and a 52-week low of $47.32.

In the last year, Haemonetics(HAE) shares hit a 52-week high of $89.69 and a 52-week low of $47.32.

HAE News

Simply Wall St 21h
Is There Opportunity in Haemonetics After Shares Surge 57% on Expansion News?

Thinking about whether Haemonetics is a savvy investment right now? Let’s dive into what the market is signaling and where the opportunity may lie for new and e...

Is There Opportunity in Haemonetics After Shares Surge 57% on Expansion News?
Nasdaq 2d
Haemonetics Reaches Analyst Target Price

In recent trading, shares of Haemonetics Corp. (Symbol: HAE) have crossed above the average analyst 12-month target price of $80.40, changing hands for $80.63/s...

Haemonetics Reaches Analyst Target Price

Analyst ratings

82%

of 11 ratings
Buy
81.8%
Hold
18.2%
Sell
0%

People also own

Based on the portfolios of people who own HAE. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.